India is the largest provider of generic drugs globally. The Indian pharmaceutical sector supplies more than 50% of global demand for different vaccines, 40% of US generic demand and 25% of all medicines in UK. India's domestic market turnover in 2019 amounted to Rs 1,4 lakh crore (USD 20,03 billion), with Rs 129,015 crore (USD 18.12 billion) growing by 9,8% year-on-year (in Rs) in 2018. India has an important role in the world pharmaceutical industry. The country also has a large pool of scientists and engineers who are able to push the industry to a higher level. Today, more than 80% of the antiretroviral used globally in the fight against AIDS (Acquired Immune Deficiency Syndrome) are supplied by Indian pharmaceutical companies. This article aims to discuss the financial position of the pharmaceutical companies with special reference to working capital management using ratio analysis technique.

___________________________________________________________________________________

Keywords: Ratios, Working Capital, Operational Efficiency, Financial Analysis.